High quality botanicals for a better life

Brilliant products, with scientifically proven efficacy for the benefit of human well-being and sustainable production starting from responsible management of the supply chain, this is Indena's offer

62°AFI Symposium – Piero Iamartino’s interview

On the occasion of this interview, we spoke with Dr. Iamartino about the European Union's proposal for new pharmaceutical legislation

DNA barcoding, pioneering complete authenticity

SPONSORED POST Did you know that up to 30% of ingredients derived from plants and soldfor human consumption are not what the label declares?

Olon announces a new investment that will furtherly expand its global...

Olon, leading international API supplier, is delighted to announce an additional investment which will further expand its global platform for developing and producing potent and high potent active ingredients, with the aim of being even more flexible, integrated, and capable of meeting the customers’ needs throughout the entire API development phases and supply chain.

API: reshoring and regulatory complexity

Active pharmaceutical ingredients is a key factor for health autonomy conquest. However, it is barred because of Asian countries dependency and complex regulatory normatives: authoritative experts discuss about it in the AFI Symposium 2021

Dangerous Liaisons: the API market

"When you control the supply of medicines, you control the world" is the mantra of Rosemary Gibson, Senior Advisor of the Hastings...

CPhI Worldwide, significant expansion of APIs pipeline for Olon Group

COMPANY NEWS As in Milan (Italy) takes place CPhI Worldwide 2021, the largest international event dedicated to the pharmaceutical and chemical-pharmaceutical industry, the...

Olon Group announces the next strategic milestone of Olon Ricerca Bioscience

COMPANY NEWS A new space to produce highly potent APIs Now, we can take clients from pre-clinical to phase...
Making Community